Prothrombotic determinants of coronary atherothrombosis

被引:18
作者
Ruberg, FL [1 ]
Loscalzo, J [1 ]
机构
[1] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA
关键词
acute coronary syndrome; atherothrombosis;
D O I
10.1191/1358863x02vm448ra
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
An acute coronary syndrome (ACS) is the clinical manifestation of a thrombotic event occurring within a coronary artery narrowed by atherosclerosis. This atherothrombotic event is thought to occur following destabilizing changes within the atherosclerotic plaque, rendering it a surface on which thrombus can develop. The development and progression of this thrombus are determined by deleterious perturbations in the hemostatic equilibrium within the local environment of the plaque that favor thrombosis. Major risk factors for the development of atherosclerotic disease have been clearly established and are targets of aggressive modification in an effort to impede the development or slow the progression of disease. While conferring an increased risk for plaque development, these and other risk factors also establish a prothrombotic milieu within the microenvironment of the atherosclerotic plaque that favors thrombosis. This review seeks to address these traditional and emerging risk factors from the context of their pathologic effects on local hemostatic balance. Aggressive risk factor modification not only reduces atherosclerotic disease development and progression, but also ameliorates the prothrombotic state, and ultimately serves to reduce atherothrombotic events.
引用
收藏
页码:289 / 299
页数:11
相关论文
共 107 条
[1]   Factor XIIIA Val34Leu polymorphism does not predict risk of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) study [J].
Aleksic, N ;
Ahn, C ;
Wang, YW ;
Juneja, H ;
Folsom, AR ;
Boerwinkle, E ;
Wu, KK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (02) :348-352
[2]   CYTOKINES AND GROWTH-FACTORS POSITIVELY AND NEGATIVELY REGULATE INTERSTITIAL COLLAGEN GENE-EXPRESSION IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
AMENTO, EP ;
EHSANI, N ;
PALMER, H ;
LIBBY, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05) :1223-1230
[3]   Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors - An in vitro demonstration [J].
Barua, RS ;
Ambrose, JA ;
Saha, DC ;
Eales-Reynolds, LJ .
CIRCULATION, 2002, 106 (08) :905-908
[4]   Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses [J].
Basta, G ;
Lazzerini, G ;
Massaro, M ;
Simoncini, T ;
Tanganelli, P ;
Fu, CF ;
Kislinger, T ;
Stern, DM ;
Schmidt, AM ;
De Caterina, R .
CIRCULATION, 2002, 105 (07) :816-822
[5]  
Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.0.CO
[6]  
2-G
[7]   beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction - The ECTIM study [J].
Behague, I ;
Poirier, O ;
Nicaud, V ;
Evans, A ;
Arveiler, D ;
Luc, G ;
Cambou, JP ;
Scarabin, PY ;
Bara, L ;
Green, F ;
Cambien, F .
CIRCULATION, 1996, 93 (03) :440-449
[8]   Effect of the PlA2 alloantigen on the function of β3-integrins in platelets [J].
Bennett, JS ;
Catella-Lawson, F ;
Rut, AR ;
Vilaire, G ;
Qi, WW ;
Kapoor, SC ;
Murphy, S ;
FitzGerald, GA .
BLOOD, 2001, 97 (10) :3093-3099
[9]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[10]   PLATELET AND COAGULATION-FACTORS IN PROLIFERATIVE DIABETIC-RETINOPATHY [J].
BORSEY, DQ ;
PROWSE, CV ;
GRAY, RS ;
DAWES, J ;
JAMES, K ;
ELTON, RA ;
CLARKE, BF .
JOURNAL OF CLINICAL PATHOLOGY, 1984, 37 (06) :659-664